Back to Screener

Healthcare

ASLAN Pharmaceuticals Limited(ASLN)

Live Price

Offline

$0.60

-14.27% today

1Y Change

Window

No data

Market Cap
$777.12M
Revenue Growth
0.0%
EPS Growth
+26.9%
Dividend Yield
0.0%
No coverage

Historical coverage is still loading

We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.

No price data

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

ASLAN Pharmaceuticals Limited (ASLN) is a Healthcare stock with a market cap of $777.12M. The stock last traded around $0.60. Baseline metrics include revenue growth of 0.0%, EPS growth of +26.9%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +26.9%, free cash flow -20.7% with operating margin -364.5% and ROIC -323.1%. Valuation already assumes a fairly strong business story at price/sales 64.8. Stock Foundry combines ASLN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

ASLN

Normalized return

SPY

S&P 500

Excess Return

Relative to SPY

ASLN Max Drawdown

Trailing 1Y

SPY Max Drawdown

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for ASLN and SPY.

Calendar-year return history is still loading or unavailable.

ASLN Dividend History

Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.

unknown

Dividend Yield

No active yield

Trailing 12M Payout

$0.00

Last Payout

No dividend events on file for this ticker yet.
No upcoming dividends in the next 90 days

Next Step

Go deeper on income quality

Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.